Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Neohesperidine Dc
2. Neohesperidine Dihydrochalcone
1. 20702-77-6
2. Nhdc
3. Neohesperidin Dc
4. Neohesperidin Dhc
5. Neohesperidine Dihydrochalcone
6. Neohesperidine
7. Nci-c60764
8. Neohesperidin-dihydrochalcone
9. Neosperidin Dihydrochalcone
10. 1-[4-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2,6-dihydroxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)propan-1-one
11. Neohesperidin Dihydrochalone
12. Chebi:83535
13. 3x476d83qv
14. 1-(4-((2-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2,6-dihydroxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)propan-1-one
15. 1-propanone, 1-[4-[[2-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2,6-dihydroxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)-
16. Citrosa
17. Neohesperidine Dc
18. 1-(4-(((2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)tetrahydro-2h-pyran-2-yl)oxy)-2,6-dihydroxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)propan-1-one
19. 1-propanone, 1-(4-((2-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2,6-dihydroxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)-
20. Ccris 4848
21. Einecs 243-978-6
22. Unii-3x476d83qv
23. Neohesperidin Dihydrochalcone (nhdc)
24. Neosperidin-dihydrochalcone
25. Dsstox_cid_5706
26. Dsstox_rid_77887
27. Dsstox_gsid_25706
28. 1-(4-((2-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2,6-dihydroxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)-
29. 1-propanone, 1-(4-((2-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2,6-dihydroxyphenyl)-3-(3-hydroxy-4-me
30. 3,5-dihydroxy-4-(3-hydroxy-4-methoxyhydrocinnamoyl)phenyl) 2-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside
31. Glucopyranoside, 3,5-dihydroxy-4-(3-hydroxy-4-methoxyhydrocinnamoyl)phenyl 2-o-(6-deoxy-alpha-l-mannopyranosyl)-, Beta-d-
32. Schembl909958
33. Chembl1159645
34. Dtxsid3025706
35. Fema No. 3811
36. Itvgxxminpyuhd-cuvhlrmhsa-
37. Hms3884h13
38. Hy-n0154
39. Zinc4175639
40. Tox21_200303
41. S2331
42. 1-(4-((2-o-[6-deoxy-&alpha
43. Akos015895239
44. Ccg-270237
45. Cs-6419
46. Ncgc00091109-01
47. Ncgc00091109-02
48. Ncgc00091109-04
49. Ncgc00257857-01
50. 1-(4-((2-o-[6-deoxy-alpha-l-mannopyranosyl]-beta-d-glucopyranosyl)oxy)-2,6-dihydroxyphenyl)-3-[3-hydroxy-4-methoxyphenyl]-1-propanone
51. 3,5-dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenyl 2-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside
52. Ac-34860
53. As-15190
54. Glucopyranoside, 3,5-dihydroxy-4-(3-hydroxy-4-methoxyhydrocinnamoyl)phenyl 2-o-(6-deoxy-.alpha.-l-mannopyranosyl)-, .beta.-d-
55. Glucopyranoside, 3,5-dihydroxy-4-(3-hydroxy-4-methoxyhydrocinnamoyl)phenyl-2-o-(6-deoxy-alpha-l-mannopyranosyl)-, Beta-d-
56. Neohesperidin Dihydrochalcone [mi]
57. Neohesperidin Dihydrochalcone, >=96%, Fg
58. Neohesperidin Dihydrochalone [fhfi]
59. Cas-20702-77-6
60. Neohesperidin Dihydrochalcone [inci]
61. Neohesperidine Dihydrochalcone [fcc]
62. N0675
63. Neohesperidin Dihydrochalcone [usp-rs]
64. Neohesperidin Dihydrochalcone, >=95% (hplc)
65. Neohesperidine Dihydrochalcone [usp-rs]
66. Neohesperidin Dihydrochalcone, Analytical Standard
67. 702n776
68. A814825
69. Q424595
70. Sr-01000883756
71. Neohesperidin-dihydrochalcone [ep Monograph]
72. Q-201457
73. Sr-01000883756-1
74. Brd-k61032563-001-02-9
75. Hesperetin Dihydrochalcone-4'-.beta.-neohesperidoside
76. Neohesperidin Dihydrochalcone, European Pharmacopoeia (ep) Reference Standard
77. Neohesperidin Dihydrochalcone, United States Pharmacopeia (usp) Reference Standard
78. 1-(4-((2-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-dihydrochalcone Glucopyranosyl)oxy)-2,6-dihydroxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)propan-1-one
79. 1-(4-((2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)tetrahydro-2h-pyran-2-yloxy)-2,6-dihydroxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)propan-1-one
80. 1-[4-[(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-2-[(2r,3r,4s,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl]oxy-tetrahydropyran-3-yl]oxy-2,6-dihydroxy-phenyl]-3-(3-hydroxy-4-methoxy-phenyl)propan-1-one
81. 1-[4-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5
82. 1-[4-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-2,6-dihydroxy-phenyl]-3-(3-hydroxy-4-methoxy-phenyl)propan-1-one
83. 1-propanone, 1-(4-((2-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl)oxy)-2,6-dihydroxyphenyl)-3-(3-hydroxy-4-methoxyphenyl)-
84. Glucopyranoside, 3,5-dihydroxy-4-(3-hydroxy-4-methoxyhydrocinnamoyl)phenyl 2-o-.alpha.-l-rhamnopyranosyl-
Molecular Weight | 612.6 g/mol |
---|---|
Molecular Formula | C28H36O15 |
XLogP3 | -0.3 |
Hydrogen Bond Donor Count | 9 |
Hydrogen Bond Acceptor Count | 15 |
Rotatable Bond Count | 10 |
Exact Mass | 612.20542044 g/mol |
Monoisotopic Mass | 612.20542044 g/mol |
Topological Polar Surface Area | 245 Ų |
Heavy Atom Count | 43 |
Formal Charge | 0 |
Complexity | 882 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?